NEWS

Press Releases

Human Longevity, Inc. (HLI) Hires Key Oncology Leader, Kenneth J. Bloom, M.D., to Head Oncology and Immunotherapy Program

Stephen P. Schoenberger, Ph.D., to head cancer vaccine program and Ezra Cohen, M.D. is staff oncologist

(SAN DIEGO, CA)—February 3, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today the appointment of several key people for its oncology genomics program. Kenneth J. Bloom, M.D. will join the company as the new head of oncology and immunotherapy; Stephen P. Schoenberger, Ph.D. will lead cancer vaccine efforts and Ezra Cohen, M.D., who is also Associate Director and Professor of Medicine, Moores Cancer Center, University of California, San Diego, will be a staff oncologist.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity Inc. Advances Leadership Role in Newborn Genome Sequencing with Strategic Acquisition of Stem Cell Banking from Celgene Cellular Therapeutics

HLI to Offer Newborn Genome Sequencing Product in Combination with Stem Cell Banking

(SAN DIEGO, CA)—January 28, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has agreed to purchase LifebankUSA, a leader in placental and cord blood banking, along with its proprietary and high-yield method for extracting placental stem cells and related therapeutic programs, and the biomaterials program which includes the marketed product Biovance®, a cell matrix critical to wound healing applications.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. (HLI) to Offer Oncology Products Including Comprehensive Whole Germline, Tumor Genome and Whole Cancer Exome Products

(SAN DIEGO, CA)—January 12, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today its oncology genomics program, including the development of comprehensive whole germline and tumor genome analysis, as well as tumor and germline exome analysis products.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. (HLI) Acquires Cypher Genomics, Inc.

Cypher CEO, Ashley Van Zeeland, Ph.D. to become head of HLI’s Pediatric Business

(SAN DIEGO, CA)—November 30, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions. The San Diego-based company has 14 employees who will join HLI including Cypher CEO and Co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI’s Pediatric Business. Financial details of the deal were not disclosed.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Hires Sally A. Howard as Head of Regulatory Affairs and Policy

(SAN DIEGO, CA) November 4, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that Sally Howard, J.D., has been hired as Head of Regulatory Affairs and Policy. Howard, who has more than two decades of health policy and regulatory expertise, will lead all efforts related to federal and state regulatory oversight for HLI.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. and Venter Institute Scientists Publish Paper Demonstrating Inconsistency in Microbiome Studies due to Variable Approaches to DNA Sequencing and Data Analysis

Comparison of four common library prep methods found significant differences in types of microbes uncovered and showed biases in error and duplication rates

(SAN DIEGO, CA)—October 26, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that its researchers along with those from the J. Craig Venter Institute and the University of California, San Diego, have published a paper in the journal, Proceedings of the National Academy of Sciences (PNAS), outlining the confusing and conflicting microbiome results generated by a variety of next generation sequencing technology. They also outline recommendations for new research community standards in the microbiome research field given these differences. The paper is being published this week in the early online edition of PNAS.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Launches the Health Nucleus, a Comprehensive and Personalized Health Platform for Individuals

(SAN DIEGO, CA) OCTOBER 13, 2015 – Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today the launch of the company’s first Health Nucleus™, a genomic powered clinical research project that has the potential to transform healthcare. The inaugural Health Nucleus is located in San Diego, CA, at HLI’s headquarters facility. More Health Nucleus facilities are slated to open in 2016 in other US and International cities.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Appoints William A. Roper, Jr. as Chief Financial Officer

(SAN DIEGO, CA) September 28, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that William A. Roper, Jr. has been appointed Chief Financial Officer, reporting directly to HLI’s CEO, J. Craig Venter, Ph.D. Roper joins the company full-time after serving as interim CFO.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. and Discovery Ltd to Offer Whole Exome, Whole Genome and Cancer Genome Sequencing to Discovery Insurance Clients in South Africa and the United Kingdom

HLI Introduces a Whole Exome Sequencing Product for $250 USD

(SAN DIEGO, CA and SANDTON, SOUTH AFRICA)—September 22, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, and Discovery Ltd, a pioneering insurer dedicated to making people healthier, announced today that the two companies have entered into a multi-year agreement to offer whole exome, whole genome and cancer genome sequencing to Discovery’s clients in South Africa and the United Kingdom.
(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Hires Life Sciences Leader, Mark Winham, as Chief Operating Officer

(SAN DIEGO, CA) August 25, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that Mark A. Winham has joined the company as Chief Operating Officer. Winham, who brings more than 25 years of life sciences, medical operations and technical experience, will report directly to HLI’s CEO, J. Craig Venter, Ph.D. (more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets